Topic profile page for Keryx.
This page has aggregated data from forum posts, threads, listings, online discussions, newsgroups, messageboards, and other online sources which contain user generated content for the term: Keryx.
Topic "Keryx" was discussed 0 times on 0 sites in last 3 months
Started 1 week, 1 day ago (2009-12-16 13:02:41)
by 0815ax
Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Adva Date : 12/16/2009 @ 8:30AM Source : PR Newswire Stock : (KERX) http://ih.advfn.com/p.php?pid=nmona&article=407857 55&symbol=KERX Trial conducted pursuant to Special Protocol Assessment with the Food and Drug Administration NEW YORK, Dec. 16 /PRNewswire-FirstCall/ -- ...
Started 2 weeks, 3 days ago (2009-12-07 11:34:47)
by 0815ax
Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Trea Date : 12/07/2009 @ 8:30AM Source : PR Newswire Stock : Keryx Biopharmaceuticals (MM) (KERX) http://ih.advfn.com/p.php?pid=nmona&cb=1260203607& article=40663317&symbol=N^KERX
Started 2 weeks, 3 days ago (2009-12-07 09:11:51)
by surf1944
8:31AM Keryx Biopharma reports updated Phase 1/2 data, including new survival data, on KRX-0401 in the treatment of advanced mltiple meloma (KERX) 3.10 : Co announces announced updated efficacy and safety data as well as new survival data on the clinical activity of KRX-0401 in combination with bortezomib in patients with relapsed/refractory multiple myeloma. Data from the study entitled "A ...
Started 2 weeks, 6 days ago (2009-12-04 12:22:23)
by 0815ax
Keryx Biopharmaceuticals, Inc. at Piper Jaffray Healthcare Conference Wednesday, December 2, 2009 10:30 a.m. ET Webcast Presentation: http://investors.keryx.com/phoenix.zhtml?p=irol-ev entDetails&c=122201&eventID=2566261
Started 2 weeks, 6 days ago (2009-12-04 12:20:13)
by 0815ax
Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology [b]Updated Analyses of Phase 1/2 Clinical Trial of KRX-0401 in Combination with Bortezomib (+/- Dexamethasone) to be Presented on Saturday, December 5, 2009[/b] http://investors.keryx.com/phoenix.zhtml?c=122201& p=irol-...
Started 2 weeks, 6 days ago (2009-12-04 12:19:03)
by 0815ax
Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology Updated Analyses of Phase 1/2 Clinical Trial of KRX-0401 in Combination with Bortezomib (+/- Dexamethasone) to be Presented on Saturday, December 5, 2009 http://investors.keryx.com/phoenix.zhtml?c=122201& p=irol-newsArticle&...
Started 14 hours, 28 minutes ago (2009-12-24 10:31:00)
by professor_ra...
KERX, Fast Track Multi-Cancer Drug Begins Phase 3, Short Squeeze in the Making The last time I brought KERX (Keryx Biopharmaceuticals) to your attention, it was trading under $2. Since then it reached new 52 highs of $3.45. It is interesting to note that on Fast Track news and Phase 3 news, it appears a group went short at the 52 week high as they were trying to reach their options ...
Started 1 week, 1 day ago (2009-12-16 09:31:11)
by surf1944
Aterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma .Companies:Aeterna Zentaris Inc..Press Release Source: AETERNA ZENTARIS INC. On Wednesday December 16, 2009, 8:35 am Trial conducted pursuant to Special Protocol Assessment with the Food and Drug Administration QUEBEC CITY, Dec. 16 /...
Started 6 days, 15 hours ago (2009-12-18 09:23:00)
by surf1944
7:17AM AEterna Zentaris announces termination of agreement with sanofi-aventis (SNY) U.S. for the development, commercialization and licensing of Cetrorelix in benign prostatic hyperplasia (AEZS) 0.86 : Co announces the termination of its agreement with sanofi-aventis U.S. (SNY) dated March 5, 2009 for the development, commercialization and licensing of cetrorelix in benign prostatic hyperplasia ...
Started 1 day, 9 hours ago (2009-12-23 15:52:38)
by thekrup
Bought KERX at 2.61 because of the last part of this article. UPDATE 1-Aeterna, Sanofi end prostate drug pact Fri Dec 18, 2009 8:14am EST Stocks * To turn attention to other treatments TORONTO, Dec 18 (Reuters) - Canadian drugmaker Aeterna Zentaris (AEZ.TO) said on Friday that it would end a development deal with Sanofi-Aventis (SNY.N) (SASY.PA) for an enlarged-prostate drug following ...
Started 4 days, 8 hours ago (2009-12-20 16:20:00)
by I seeJesus
Squirrel222 wrote: I will ask you my original post: If you say yes, then why did he have to harden the pharoah's heart ( multiple times ) to get him to oppose god? What does that say about god to make a man oppose him to prove his greatness? You may say "pharoah was created for this purpose." Then how can god blame him on judgement day for something that was not of his control? --One ...
